Theme: Beat Goes on, with a Wealthy Heart
Cardiology Care 2020
ME Conferences organizes 300+ conferences, 500+ workshops and 200+ symposiums on Clinical, Medicine, Pharma and Science & Technology. Cardiology events are every year across UK, Europe, Asia, Middle East, Australia and USA that support cardiology conferences from 1000 more scientific societies and Publishes 100+ open access journals which contain over 30000 eminent personalities, reputed scientists as editorial board members. Cardiology Care 2019 comes under Cardiology medical conferences.
With the coordination of the Organizing Committee, we are gratified to be framework the program for the 30th International Conference on Cardiology and Healthcare, August 10-11, 2020 in Dubai, UAE. Our conference includes a well-proportioned cast of speakers, covering both generous and precise topics of concernment. Our conference intents to provide cardiac physicians, specialists, nurses, technologist, professors, students and anyone professionally involved in Cardiac Care with an opportunity to learn about the multiplicity of the Cardiac Care, discuss interventional procedures, look at sophisticated cardiac practices and their efficacy and efficiency in the treatment of various cardiac cases, and comprehend practical constraints in improving healthcare. The Cardiology Care 2020 will be organized encompassing the theme "With Wealthy Heart-The Beat Goes On".
Millions of individuals across the globe are affected by cardiac disorders – some are minor and others are critical. As per World Health Organization (W.H.O.) research, more than 19.5 million people have CVDs, an estimated 45.1% of all deaths worldwide and 80% of all CVD deaths are due to heart attacks and strokes. According to the market study, the global market for Cardiovascular Disease is expected to grow from $16..7 billion to $20.2 billion by 2020. An extreme part of research is going on Cardiology in the top Universities across the globe. Many companies are associated with various diagnostic instruments and other therapeutics. Besides these various societies and research labs are also associated in this research field.
This is a distinctive international meeting where cardiologists, pediatrics and congenital heart rhythm professionals can meet their colleagues from around the world, and exchange ideas and new information in the field of Cardiac Care. The Program is designed for people who are actively involved in the management of Cardiac Care. We have gathered a renowned international faculty, and attendees will gain the opportunity to learn and receive innovations about the latest knowledge in Cardiac Care.
Cardiology Care 2020 invites all interested participants to consolidate us for this honoured event at the gorgeous destination Dubai, UAE. For more information: ME Conferences
Why to attend?
30th International Conference on Cardiology and Healthcare is among the World's leading Scientific Conference. The three-day event on Cardiology practices will host 60+ Scientific and technical sessions and sub-sessions on innovative researches in the field of cardiology and healthcare across the globe. Cardiology Care 2020 will constitutes of 15 major sessions designed to offer comprehensive sessions that states current issues in the various field of Cardiology and Cardiac Healthcare.
The attendees can find exclusive sessions and panel discussions on latest innovations in Advanced Cardiac treatments and Cardiac Surgeries and by:
- Lectures from renowned speakers
- Keynote forums by Prominent Professors, Doctors
- Open Innovation Challenges
- Poster presentations by Young Researchers
- Global Networking sessions with 50+ Countries
- Novel techniques to benefit your research
- Best platform for Global business and Networking opportunities
- Meet the editors of referred journals, Society and Association members across the Globe
- Excellent platform to showcase the latest products and formulations in Cardiac field
- Cardiac Surgeons
- University Professors
- Various Societies and their members
- Institutes-Medical Schools Students
- Research Scholars
- Business Entrepreneurs
- Training Institutes
- Software making associations
- Manufacturing Medical Devices Companies
Recent clinical bulletin addressing the cardiac implications of the novel coronavirus (COVID-19, 2019-nCoV and Wuhan Coronavirus. The key message to clinicians is that patients with underlying cardiovascular disease may have a potential increased risk if they contract coronavirus
The bulletin provides background on the epidemic, which was first reported in late December 2019, and looks at early cardiac implications from case reports. It also provides information on the potential cardiac implications from analogue viral respiratory pandemics and offers early clinical guidance given current 2019-nCoV uncertainty. It stresses the importance for cardiovascular disease patients to remain current with vaccinations, including the pneumococcal vaccine given the increased risk of secondary bacterial infection and suggests encouraging the influenza vaccination to prevent another source of fever which could be initially confused with coronavirus infection.
Track: Cardiology and Hypertension
Cardiology is a medical specialty and a branch of internal medicine concerned with disorders of the heart. It deals with the diagnosis and treatment of such conditions as congenital heart defects, coronary artery disease, electrophysiology, heart failure and valvular heart disease. Subtopics of the cardiology include cardiac electrophysiology, echocardiography, interventional cardiology and nuclear cardiology. Hypertension is Blood pressure is the force that a person's blood exerts against the walls of their blood vessels. For cardiovascular diseases, including stroke, heart attack, heart failure, and aneurysm hypertension is a primary risk factor. Treatment drugs for hypertension include diuretics, including thiazides, chlorthalidone, and indapamide, beta-blockers and alpha-blockers, calcium-channel blockers, central agonists, peripheral adrenergic inhibitor, vasodilators, angiotensin-converting enzyme (ACE) inhibitors, angiotensin receptor blockers.
Heart failure is a complex clinical disorder which is a outcome of various primary and secondary causes, and shared pathways of disease progression, relating with considerable mortality, morbidity and cost. Heart failure in pediatrics is most commonly associated with coexistence of congenital heart disease, with different risks depending on the specific type of malformation. The signs and symptoms in children include, poor growth, feeding difficulties, respiratory track disorders, exercise intolerance, and fatigue, and is associated with circulatory, neurohormonal imbalance, and molecular abnormalities. Congenital heart disease is frequently associated with ventricular dysfunction, volume or pressure overload.
Heart Failure in pediatric patients with CHD has various causes, some of which overlap with the causes of cardiomyopathy, resulting in both distinct and shared mechanisms leading to ventricular dysfunction and the clinical manifestation of heart failure. We focus on basic, translational, and clinical research as it applies to heart failure in pediatric patients with CHD.
The scientific goal of this track is to understand the underlying causes and pathophysiology cardio-metabolic diseases like of obesity, diabetes, and as well as pursuing effective and safe interventions and therapeutics. This includes expertise in the central nervous system that controls appetite and energy expenditure, pancreas function, and adipose tissue function. Cardio-oncology describes the efforts to prevent or treat patients with cancer who are facing with heart problems due to cancer treatments. Although many cancer patients also have health conditions related to lung disease, infections or kidney disease, the rise of cardiac diseases in these patients has led to the growth of this new field. Cardio-oncology involves oncologists, cardiologists and researchers.
Cardiomyopathies are a heterogeneous group of heart muscle diseases, including dilated (DCM), hypertrophic (HCM), restrictive (RCM), arrhythmogenic right ventricular (ARVC), and non‐classified cardiomyopathies that frequently present as the syndrome of heart failure. The variety of causes, multiple underlying pathophysiological mechanisms and different phenotypic expressions influence their presentation and response to treatment. Although patients with cardiomyopathies have been represented in clinical trials, distinct features of their therapeutic responses, relative to other aetiologies of HF, remain unknown.
Health education, advice on cardiovascular risk reduction, physical activity and stress management are the interventions offered to patients with heart diseases in cardiac rehabilitation. Cardiac rehabilitation reduces mortality, morbidity, unplanned hospital admissions in addition to improvements in exercise capacity, quality of life and psychological well-being is increasing, and it is now recommended in international guidelines. Cardiac rehabilitation is the evidence of its benefit and effects on cardiovascular mortality, morbidity and quality of life.
Track: Heart Regeneration
Cardiac Regeneration is an effort to repair irreversibly damaged heart tissue through cutting-edge science, including stem cell and cell-free cell therapy. Reparative tools have been designed to restore damaged heart tissue and function by the natural ability of the body to regenerate. Together, patients and providers find regenerative solutions that renew, renew and recycle patients' own reparative capabilities.
- Heart Regeneration in Lower Vertebrates
- Limited Regeneration in Rodent Hearts
- The Evidence for Human Heart Regeneration
- Stem Cells and Cell Therapy
- Reprogramming Fibroblasts to Cardiomyocytes
- Tissue engineering
Cardio-metabolic disorders are assemblage of health circumstances associated with cardiovascular disease and diabetes. The morbidity and mortality severity increased clinical attention to address risk factors predisposing individuals to these cardiovascular disorders. Obesity increases the risk for heart disease and stroke. But it damages more than just the circulatory system. It even causes gallstones, osteoarthritis and respiratory problems. Obesity also can lead to heart failure. Stroke and coronary heart disease can be caused by the atherosclerosis. The medical conditions and their related risk-factors can control the complications by evidence based treatments while improving health literacy in foremost Healthcare Conferences.
Track: Cardiovascular Engineering
Cardiovascular Engineering is a wide spectrum of research, from basic to transitive in all attributes of cardiovascular physiology and medical treatment. The distribution of research that utilizes engineering principles and methods to enhance basic knowledge and technological solutions related to cardiovascular system. Coverage ranges from subcellular to systems level topics, including other implantable medical devices such as hemodynamics, tissue biomechanics, functional imaging, surgical devices, electrical physiology, tissue engineering and regenerative methods, diagnostic tools, transmission and delivery of biologics and biosensors. Other new innovative methods are still under developing stage and can be interpreted in various Cardiology Meetings.
An innovative therapeutic approach is the use of cell therapy to counteract reverse ventricular remodelling, the substrate of heart failure and arrhythmias following myocardial infarction. Advantageous cell tissue regeneration combines a complex cellular and molecular advent setting that includes stem cell grafting and differentiation, secretion of anti-inflammatory and angiogenic mediators, and proliferation of endogenous cardiac stem cells. Recent therapeutic approaches involve adipose-derived stem cells, heart-derived stem cells, bone marrow-derived mononuclear cells and mesenchymal stem cells, and combinations of cells. Clinical trials using mesenchymal stem cells and cardiac derived stem cells have been shown to be effective in reducing infarct size and improving the contractility of regional walls. More research in undergoing in this concern and discussed in many of the Cardiology Congress.
Track: Sports Cardiology
Sports cardiology is an advancing field that encompasses the care of athletes and active individuals with known or previously undiagnosed cardiovascular conditions. It incorporates many aspects of cardiology, such as cardiac imaging, electrophysiology, structural heart disease and exercise physiology. A comprehensive sports cardiology program should include physicians with specific knowledge within these fields. The sports cardiology team should include those with expertise in the pediatric heart, especially congenital heart disease and inherited diseases, cardiovascular imagers, electrophysiologists, heart failure specialists and exercise physiologists.
Track: Women Cardiology
Cardiology rate of increase for women much slower than other areas. Overwhelming majority of women work full-time 33% of women performed fluoro- procedures while pregnant. 29% of women did not receive any information about radiations.
Cardiovascular diseases continue to be the leading cause of death among women in the states. Sex-specific data focused on cardiovascular disease have been increasing steadily yet is not routinely collected nor translated into practice. This comprehensive review focuses on novel and unique aspects of cardiovascular health in women and sex differences as they relate to clinical practice in the prevention, diagnosis, and treatment of cardiovascular disease.
- Pregnancy-related disorders and CVD risk association
- Persistence of weight gain after pregnancy
- Radiation and chemotherapy for breast cancer
- ASA in women with diabetes mellitus
- Ischemic heart disease in women
- Acute coronary syndromes in women.
Track: Cardiology - Future Medicine
A cardiologist is a doctor who specializes in the studies of heart & its functions & also diagnosis, treatment and preventing diseases related to heart and blood vessels. You might also visit a cardiologist, so you can learn about your risk factors for heart disease and find out what measures you can take for better heart health. Cardiology – Future medicine is a field which is changing rapidly, New technologies as drug-eluting stents, assist devices for left ventricle, and novel inflammatory markers, and imaging modalities such as magnetic resonance imaging and 3D echocardiography.
- General clinical cardiologists
- Pediatric cardiologists
- Cardiovascular Anesthesiology
- Cardiovascular Pathology Research
- Preventive cardiologists.
30th International Conference on Cardiology and Healthcare welcomes presenters, exhibitors and attendees from all over the globe to Dubai, UAE during August 10-11, 2019. The organizing committee is preparing for an appealing and informative conference program including lectures, workshops, symposia on a wide category of topics, poster presentations, young researcher forums and various programs for participants from across the globe. We graciously invite you to unite us at the International Conference on Cardiology and Healthcare, where you will have a intelligible experience with scholars from overseas. Organizing committee and all attendees of Cardiology Care 2020 look forward to meet you at Helsinki, Finland.
Scope and importance:
Cardiology is a branch of medicine dealing with disorders of the heart. It includes medical diagnosis and treatment of Coronary Artery Disease, Heart Failure, Valvular Heart Disease, Electrophysiology, Inherited Heart Disease and Congenital Heart Defects. Cardiologists study the dysfunctions of the heart, but the study of adult and child heart disorders are through dissimilar training pathways. Therefore, an adult cardiologist (often qualified and called just "cardiologist") is not fully trained to take care of children, and paediatric cardiologists are inadequately trained for adults. The surgical feature are not included in cardiology and are in the discipline of cardiothoracic surgery, For example, Cardiopulmonary bypass and Coronary artery bypass surgery are two surgical procedures performed by Cardiac surgeons, not cardiologists.
Why Dubai :
Dubai is the capital and the most populous city of the United Arab Emirates. Dubai is the wealthiest emirate of the UAE in terms of Gross Domestic Product (GDP) and per capita income. More than $3 trillion is invested worldwide in this city alone. In 2019, the GDP per capita also reached $83,400, which ranks 4th in the world after Qatar, Liechtenstein and Luxembourg and many others.
- Clinical Cardiology
- Interventional cardiology
- Neonatal Cardiology
- Cardiac Nursing
- Cardiac Diseases
- Heart failure
- Cardiovascular Medicine
- Cardiac Surgery
- Cardiometabolic Health- Diabetes, Obesity, & Metabolism
- Cardiovascular Engineering
- Rehabilitation of Cardiovascular Diseases and Healthcare
- Cardiac Pharmacology
- Stem Cell Research and Regeneration on Cardiology
- Clinical Case Reports on Cardiology
Why to attend???
With members from around the globe focused on learning about Cardiology, this is your single best opportunity to reach the largest assemblage of participants from the hospitals, Universities, community, etc. This Cardiology Conference will conduct demonstrations, distribute information, meet with current and potential researchers and receive name recognition at this 2-day event. World-renowned speakers, the most recent techniques, tactics, and the newest updates in Cardiology field are hallmarks of this conference.
According to Statistics MRC, the Global Stroke Diagnostics and Therapeutics market is reckoned for $27,658.49 Million in 2019 and is estimated to reach $54,731.54 Million by 2030 growing at a CAGR of 11.5% during the forecast period.
Factors like technological advancement, a growing aging population, and people affected by diabetes, high blood pressure are favouring the market. On the other hand, increasing health expenditure, cardiovascular diseases and increasing tobacco users are supplying the market.
Hypertension is a chronic medical condition during which the blood pressure is elevated to an unsought level. Hypertension is a chronic disease, which means that a patient could need to require medications a day for the rest of his/her life. Thus, the demand for anti-hypertensive medication is property and can increase with a rise within the variety of target patients. Anti-hypertensive drugs were the second largest therapy area in 2019 with the worldwide sales worth of over USD 55 billion; according to the globe Preview 2018 report by valuate Drug Company.
Some of the key factors contributing to the worldwide anti-hypertensive medication market include Novartis AG, Pfizer, Inc, Johnson & Johnson Ltd, Sanofi S.A., Lupin Limited, Ranbaxy Laboratories Limited, Merck & Co., Inc., Astra Zeneca Plc, Daiichi Sankyo Company Limited, and Takeda Pharmaceutical Company Limited.
Recent research report analyses anti-hypertensive medication market counting on its market segments, major geographies, and current market trends. Geographies analysed under this analysis report include
- North and South America
- Asia Pacific
- Rest of the World
Countries in Middle East bear a heavy burden from Ischemic heart disease. According to, Dubai Health Authority, Heart disease is the cause for every 4 in 10 deaths in the UAE. Huge funding in R&D and various initiatives by government is driving the growth for Ischemic heart Disease market in Middle East. Middle-East Ischemic heart Disease market is growing steadily. The market is growing at the CAGR of 5.8% and expected to reach to US$ 4.73 billion by 2021. UAE market for medical devices and materials continues to be among the world largest from few years. As per the latest official figures from the Ministry of Health, Labour and Welfare (MHLW) and Annual Pharmaceutical Production Statistics, the UAE market for cardiology medical devices and materials in 2019 was approximately $45.1 billion. UAE total imports of U.S. medical devices were approximately $9.2 billion in 2019. In the near-term, the market is expected to increase due to UAE aging population and continued demands for advanced medical technologies.
The total UAE market for interventional cardiology devices is growing at a rate of 4.1%, which will take the 2019 market value of $151,896 up to $166,789 by 2024. UAE hospitals tend to gravitate towards the more expensive and technologically advanced devices. The total market value includes a large number of segments such as the coronary stent, coronary balloon catheter, balloon-inflation device, interventional coronary catheter, interventional coronary guide wire, introducer sheath, coronary vascular closure device, diagnostic coronary catheter and guide wire, fractional flow reserve (FFR) guide wire, intravascular ultrasound (IVUS) catheter, and optical coherence tomography (OCT) catheter market.
Global cause of death due to heart diseases: By 2030 almost about 60% of the deaths are supposed to occur due to cardiac diseases when compared to deaths with other diseases globally.
Cardiology Universities in Dubai
- Mohammed Bin Rashid University Of Medicine and Health Sciences
- Murdoch University Dubai
- Dubai Medical College
- German Heart Centre Bremen FZ-LLC
- University of Wollongong in Dubai (UOWD)
- Zayed University
- College of Medicine University of Sharjah
- KidsHeart Medical Center Dubai
- Curtin University Dubai
- American University in the Emirates
- Amity University Dubai campus
- Manipal Academy of Higher Education - Dubai Campus
- University of Dubai
- Middlesex University Dubai
- University of Sharjah
- American University in Dubai
- Heriot-Watt University Dubai
- Canadian University Dubai
- Gulf Medical University
- Birla Institute of Technology & Science, Pilani - Dubai Campus
Worldwide Cardiology Universities
- Duke University
- University of Pennsylvania
- University of Michigan
- The University of Utah
- University of Rochester
- The University of Chicago
- Emory University
- University of Minnesota
- Northwestern University
- University of Mn Med School
- Rush University Cardiologists
- UAB Cardiovascular Disease Administrative Office
- University of Florida
- Indiana University School of Medicine
- Northwestern University Feinberg School of Medicine
- Indiana University School of Medicine
- Creighton University
- The University of Arizona
- American College of Cardiology
- Rush University
Societies Associated with Cardiology Research:
- The American Heart Association
- International Society for Heart Research (ISHR)
- Association for European Pediatric Cardiology
- American Association of Heart Failure Nurses (AAHFN)
- Heart Valve Society of America (HVSA)
- Heart Failure Society of America
- Society of Invasive Cardiovascular Professionals
- European Society of Cardiology
- Working Group for Cardiac Magnetic Resonance Spanish Society of Cardiology
Industries Associated with Cardiology Research:
- Medtronic, Inc.
- Boston Scientific Corporation
- St. Jude Medical, Inc.
- Abbott Laboratories
- Cordis Corporation
- BIOTRONIK SE & Co. KG
- Sorin S. P. A.
- Edwards Life sciences Corporation
- Terumo Corporation
- Biosense Webster, Inc.
- C. R. Bard, Inc.
- AGA Medical Holdings, Inc.
- MAQUET GmbH & Co. KG
- Sahajanand Medical Technologies Pvt. Ltd.
- Vascular Concepts Limited
- GE Healthcare
- Philips Healthcare
- Fukuda Denshi Co., Ltd.
- Cardiac Science Corporation
- Welch Allyn Inc.
- ZOLL Medical Corporation
- Eurocor GmbH
- B. Braun Melsungen AG
- OSI Systems, Inc.
- W. L. Gore & Associates, Inc.
- Berlin Heart GmbH
- Thoratec Corporation
- Nihon Kohden Corporation
- Teleflex Incorporated
Universities Associated with Cardiology Research:
- Harvard University
- Cornell University
- Yale University
- University of Texas South-western medical center
- University of Michigan
- University of Washington
- Harvard University
- Vanderbilt University
- University of Rochester
- University of Alabama-Birmingham
- Emory University
- Northwestern University
- Vanderbilt University
USA: The American Society for Preventive Cardiology; American Society of Nuclear Cardiology; American Heart Association; ACC; American Stroke Association; Society for Cardiovascular Angiography and Interventions; Arizona Society of Echocardiography; Brazilian Society of Cardiology; Heart Failure Society of America; Canadian Association of Cardiovascular Prevention and Rehabilitation; Elsevier Society Partners in Cardiology; American Society for Preventive Cardiology; American Society of Echocardiography; American Society of Hypertension; Brazilian Society of Hypertension; Canadian Cardiovascular Society; Argentine Society of Cardiology; Canadian Association of Interventional Cardiology; Congenital Cardiac Anaesthesia Society; The American Association of Cardiovascular and Pulmonary Rehabilitation; Vascular and Endovascular Surgery Society, American College of Cardiology, Georgian Society of Cardiology, Hellenic Society of Cardiology, Icelandic Society of Cardiology, International Society for Vascular Surgery, Irish Cardiac Society, Kosovo Society of Cardiology, Lithuanian Society of Cardiology, Luxembourg Society of Cardiology, Macedonian FYROM Society of Cardiology, Maltese Cardiac Society, Moldavian Society of Cardiology, Montenegro Society of Cardiology, Moroccan Society of Cardiology, Norwegian Society of Cardiology, Polish Cardiac Society, Portuguese Society of Cardiology, San Marino Society of Cardiology, Slovak Society of Cardiology, Slovenian Society of Cardiology, Spanish Heart Foundation, Swedish Society of Cardiology, Swiss Society of Cardiology.
Europe: European Society of Cardiology; British Cardiovascular Society; World Heart Federation; British Association for Cardiovascular Prevention and Rehabilitation; World Heart Failure Society; Austrian Heart Foundation; Austrian Society of Cardiology; Philippine Heart Association; Belgian Society of Cardiology; Spanish Society of Cardiology; British Cardiac Society; International Academy of Cardiology; British Heart Foundation; British Hypertension Society; British Junior Cardiologists Association; Croatian Cardiac Society; European Society of Cardiology; British cardiology society; Luxembourg Society of Cardiology; British Heart Failure Society; Association of Cardiologists of Bosnia & Herzegovina; British Heart Foundation; Spanish Heart Foundation; Austrian Heart Foundation; Belorussian Scientific Society of Cardiologists.
Middle-East: Algerian Society of Hypertension, Russian Society of Cardiology, Armenian Cardiologists Association, Saudi Heart Association, Turkish Society of Cardiology, Emirates Cardiac Society, Egyptian Cardiology Society, Iranian Heart Association.
Asia Pacific: Asian Pacific Society of Cardiology; Cardiac Society of Australia & New Zealand; The Japanese Heart Failure Society; Japanese Society of Echocardiography; The World Society of Cardiovascular & Thoracic Surgeons; Asian Pacific Society of Hypertension; Association of Cardiologists of Kazakhstan; Australian Cardiovascular Health and Rehabilitation Association; Association of Thoracic and Cardiovascular Surgeons of Asia; Chinese Society of Cardiology; The Pan-African Society of Cardiology; Association of Pediatric Cardiology; Cardiological Society of India; Asian Society of Cardiovascular Imaging; Association of Black Cardiologists; Interventional Cardiovascular Society of Malaysia; Israeli Cardiology and Critical Care Nursing Society; Japanese Society of Thoracic Radiology; Korean Society for Thoracic and Cardiovascular Surgery; Kyrgyz Society of Cardiology; Lebanese Society of Cardiology; The Heart foundation of Malaysia; The Japanese Society of Hypertension.
- 8thInternational Conference on Hypertension and Healthcare, August 10-11, 2020 Dubai, UAE
- 2nd Middle East Heart Congress, June 22-23, 2020 Abu Dhabi, UAE
- 16thInternational Conference on Nephrology and Hypertension, June 22-23, 2020 Abu Dhabi, UAE
- 26thInternational Conference on Human Metabolic Health-Diabetes, Obesity & Endocrinology, June 22-23, 2020 Abu Dhabi, UAE
- 3rd World Heart Rhythm Conference, October 26-27, 2020 Cape Town, South Africa
- Global Conclave on Hypertension and Healthcare Expo, November 16-17, 2020 Dubai, UAE
- 8th World Congress on Hypertension, Cardiology, Primary Health and Patient Care, June 18-19, 2020 Geneva, Switzerland
- 8th International Conference on Hypertension and Healthcare, September 23-24, 2020 Berlin, Germany
- 6thWorld Congress on Hypertension and Public Health, November 21- 22, 2018 | Paris, France
- 2ndInternational Conference on Hypertension & Healthcare, September 11-13, 2017 Amsterdam, Netherlands
- Cardiac Implications of Corona Virus
- Cardiology and Hypertension
- Congenital Heart Disease (CHD) and Pediatric Cardiology
- Cardio-metabolic Diseases and Cancer
- Cardiac Rehabilitation and Healthcare
- Heart Regeneration
- Cardio-Metabolic Health- Diabetes, Obesity, & Metabolism
- Cardiovascular Engineering
- Stem Cell Research and Regeneration on Cardiology
- Sports Cardiology
- Women Cardiology
- Cardiology - Future Medicine
To share your views and research, please click here to register for the Conference.